Re: Samuel R. Denmeade, Blair Egerdie, Gary Steinhoff, et al. Phase 1 and 2 studies demonstrate the safety and efficacy of intraprostatic injection of PRX302 for the targeted treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 2011;59:747-54.
作者信息
Cai Tommaso, Paolo Dalla Palma, Malossini Gianni
出版信息
Eur Urol. 2011 Jun;59(6):e33. doi: 10.1016/j.eururo.2011.02.037. Epub 2011 Mar 12.
PMID:21398021
Abstract
摘要
Zotero 插件